apathy (indifference)

From Aaushi
Jump to navigation Jump to search

Introduction

Indifference. A lack of interest in one's environment, including social interactions.

Etiology

Epidemiology

  • most common neurobehavioral symptom in dementia

Pathology

Clinical manifestations

Diagnostic criteria

  • Association Francaise de Psychiatrie Biologique (AFPB) & European Psychiatric Association (EPA) task force criteria for apathy in Alzheimer disease & other neuropsychiatric disorders
    • presence of quantitative reduction of goal-directed activity either in the behavioral, cognitive, emotional or social dimension in comparison to the patient's previous level of functioning
    • minimum duration of 4 weeks
    • symptoms need to present in 2 or 3 domains
    • functional impairment
    • not explained by or due to major changes in the patient's environment[3]

Complications

Management

More general terms

References

  1. Stedman's Medical Dictionary 27th ed, Williams & Wilkins, Baltimore, 1999
  2. Principles of Neurology, 4th ed, Adams RD & Victor M (eds) McGraw-Hill, Inc, New York, 1989
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
    Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  4. 4.0 4.1 4.2 Berman K, Brodaty H, Withall A, Seeher K Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry. 2012 Feb;20(2):104-22. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21841459
  5. 5.0 5.1 Padala PR, Padala KP, Lensing SY et al. Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer's disease: A double-blind, randomized, placebo-controlled trial. Am J Psychiatry 2017 Sep 15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28945120
  6. 6.0 6.1 6.2 George J Stimulant Reduces Apathy in Alzheimer's Disease Twice daily methylphenidate showed modest effect size. MedPage Today September 27, 2021 https://www.medpagetoday.com/neurology/alzheimersdisease/94722
    Mintzer J, Lanctot KL, Scherer RW et al Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease. The ADMET 2 Randomized Clinical Trial. JAMA Neurol. Published online September 27, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570180 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784538
    Fredericks C Methylphenidate for Apathy in Alzheimer Disease - Why Should We Care? JAMA Neurol. Published online September 27, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570178 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784541
  7. Robert P, Lanctot KL, Aguera-Ortiz L et al. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018;54:71-76 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30125783 Free article https://www.cambridge.org/core/journals/european-psychiatry/article/is-it-time-to-revise-the-diagnostic-criteria-for-apathy-in-brain-disorders-the-2018-international-consensus-group/5A3A2F39C4A322DCCAD6B044B4AF5CB1